NCT06849661

Brief Summary

There are still complexities regarding the effects of anesthetic drugs on bilirubin metabolism. The aim of the study was to investigate whether preoperative serum bilirubin levels are associated with the length of hospital stay after ERCP performed under sedation anesthesia in the presence of propofol. Unstable hemodynamics, increased propofol sensitivity, and prolonged recovery time to anesthetics are common features encountered in patients with hyperbilirubinemia. Therefore, close monitoring of cardiovascular functions in these patients and awareness of the possible need for a reduction in the dose of anesthetic used are the expected benefits of the study.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
360

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2025

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 15, 2025

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

February 15, 2025

Completed
12 days until next milestone

First Posted

Study publicly available on registry

February 27, 2025

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 15, 2025

Completed
16 days until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2025

Completed
Last Updated

February 27, 2025

Status Verified

February 1, 2025

Enrollment Period

8 months

First QC Date

February 15, 2025

Last Update Submit

February 25, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Preoperative bilirubin levels and length of hospital stay

    Patients' age, gender, weight in kilograms, height in centimeter, weight and height will be combined to report BMI in kg/m\^2, chronic disease history, medication history, smoking, alcohol, ASA status, being an inpatient or outpatient, Hb (hemoglobin), platelets, Na (sodium), K (potassium), INR (international normalized ratio), total bilirubin, direct bilirubin, indirect bilirubin, ALP (Alkaline phosphatase), ALT (Alanine aminotransferase), AST (aspartate aminotransferase), and hospital stay will be recorded by reviewing the case follow-up forms.

    from the beginning of the enrollment until 1 month after sedation anesthesia recovery

Study Arms (2)

Arm Low Bilirubine Levels

Arm High Bilirubine Levels

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The study will be conducted on patients who applied to the anesthesia polyclinic of SBU University Kanuni Sultan Süleyman E.A.H. and were scheduled to undergo ERCP under sedation. A total of 360 patients over the age of 18, ASA I-IV status, of both genders, who will undergo an ERCP procedure under sedation anesthesia will be included in the study.

You may qualify if:

  • years of age and older
  • ASA I-IV status
  • Both genders
  • To be operated under sedation anesthesia for ERCP procedure

You may not qualify if:

  • age \<18
  • pregnancy
  • lack of informed consent (such as patients with mental retardation or
  • language problems)
  • history of allergy to any agent used during sedation
  • baseline O2 saturation \<90%
  • baseline systolic blood pressure \<90 mmHg
  • procedure performed under general anesthesia

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sağlık Bilimleri Üniversitesi Kanuni Sultan Süleyman Eğitim ve Araştırma Hastanesi

Istanbul, 34000, Turkey (Türkiye)

Location

Biospecimen

Retention: SAMPLES WITHOUT DNA

Bilirubines (Total,direct,indirect), Amylase, AST, ALT, ALP

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
1 Month
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Specialist Anesthesiology and Reanimation, Principal Investigator

Study Record Dates

First Submitted

February 15, 2025

First Posted

February 27, 2025

Study Start

January 15, 2025

Primary Completion

September 15, 2025

Study Completion

October 1, 2025

Last Updated

February 27, 2025

Record last verified: 2025-02

Locations